Frank E. Thomas - Feb 9, 2023 Form 4 Insider Report for Orchard Therapeutics plc (ORTX)

Role
Title: President & Chief Operating Officer
Signature
/s/ Frank Thomas
Stock symbol
ORTX
Transactions as of
Feb 9, 2023
Transactions value $
$9,182
Form type
4
Date filed
2/13/2023, 07:09 AM
Previous filing
Oct 6, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORTX Ordinary Shares Options Exercise $9.18K +20K +38.4% $0.46 72.1K Feb 9, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Options Exercise $0 -20K -5.33% $0.00 355K Feb 9, 2023 Ordinary Shares 20K $0.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The shares subject to this option vest and become exercisable in twenty-four (24) equal monthly installments, with the first installment vested on March 1, 2022.

Remarks:

Title: President & Chief Operating Officer